ArticleFrontiers in immunology2023

Cost-effectiveness analysis of toripalimab plus chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer in China.

Mengdie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.